Loading...
Docoh

Unitedhealth (UNH)

UnitedHealth Group is a diversified health care company dedicated to helping people live healthier lives and helping make the health system work better for everyone. UnitedHealth Group offers a broad spectrum of products and services through two distinct platforms: UnitedHealthcare, which provides health care coverage and benefits services; and Optum, which provides information and technology-enabled health services.

Company profile

Ticker
UNH
Exchange
CEO
David Wichmann
Employees
Incorporated
Location
Fiscal year end
Former names
UNITED HEALTHCARE CORP
SEC CIK
Subsidiaries
1070715 B.C. Unlimited Liability Company • 1st Avenue Pharmacy, Inc. • 310 Canyon Medical, LLC • 4C Medical Group, PLC • 4C MSO LLC • 5995 Minnetonka, LLC • ABCO International Holdings, LLC • AbleTo, Inc. • Accurate Rx Pharmacy Consulting, LLC • Diplomat Specialty Infusion Group ...
IRS number
411321939

UNH stock data

Calendar

3 Aug 22
25 Sep 22
31 Dec 22
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 24.61B 24.61B 24.61B 24.61B 24.61B 24.61B
Cash burn (monthly) 290M (no burn) (no burn) (no burn) (no burn) (no burn)
Cash used (since last report) 832.4M n/a n/a n/a n/a n/a
Cash remaining 23.78B n/a n/a n/a n/a n/a
Runway (months of cash) 82.0 n/a n/a n/a n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
20 Sep 22 Rupert M Bondy Common Stock Grant Acquire A No No 0 7.27 0 2,310.721
20 Sep 22 Stephen J Hemsley Common Stock Grant Acquire A No No 0 23.491 0 487,395.413
20 Sep 22 Dirk C McMahon Common Stock Grant Acquire A No No 0 58.295 0 50,166.698
20 Sep 22 McSweeney Erin Common Stock Grant Acquire A No No 0 25.658 0 8,155.091
20 Sep 22 John F Rex Common Stock Grant Acquire A No No 0 59.48 0 141,567.738
86.3% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 2808 2810 -0.1%
Opened positions 156 182 -14.3%
Closed positions 158 137 +15.3%
Increased positions 1147 1192 -3.8%
Reduced positions 1159 1083 +7.0%
13F shares Current Prev Q Change
Total value 414.61B 412.04B +0.6%
Total shares 807.16M 809.16M -0.2%
Total puts 4.82M 4.52M +6.7%
Total calls 4.81M 4.58M +5.0%
Total put/call ratio 1.0 1.0 +1.6%
Largest owners Shares Value Change
Vanguard 82.12M $42.18B +1.8%
BLK Blackrock 71.71M $36.83B +3.9%
FMR 49.81M $25.59B +2.0%
STT State Street 45.87M $23.56B -0.9%
TROW T. Rowe Price 36.85M $18.93B +17.8%
Capital World Investors 34.12M $17.53B -2.0%
Wellington Management 26.54M $13.63B -5.2%
JPM JPMorgan Chase & Co. 20.25M $10.4B +20.9%
Capital Research Global Investors 19.22M $9.87B -0.3%
Capital International Investors 18.13M $9.31B -2.9%
Largest transactions Shares Bought/sold Change
TROW T. Rowe Price 36.85M +5.56M +17.8%
MS Morgan Stanley 13.5M +4.31M +46.9%
Parametric Portfolio Associates 0 -4.23M EXIT
JPM JPMorgan Chase & Co. 20.25M +3.5M +20.9%
BLK Blackrock 71.71M +2.69M +3.9%
Manufacturers Life Insurance Company, The 2.45M -2.56M -51.2%
Vanguard 82.12M +1.49M +1.8%
Wellington Management 26.54M -1.46M -5.2%
NN Investment Partners 0 -1.03M EXIT
FMR 49.81M +998.21K +2.0%

Financial report summary

?
Risks
  • We are subject to risks associated with public health crises, large-scale medical emergencies and pandemics, such as the COVID-19 pandemic, which could continue to have a material adverse effect on our business, results of operations, financial condition and financial performance.
  • If we fail to estimate, price for and manage our medical costs or set benefit designs in an effective manner, the profitability of our risk-based products and services could decline and could materially and adversely affect our results of operations, financial position and cash flows.
  • If we fail to maintain properly the integrity or availability of our data or successfully consolidate, integrate, upgrade or expand our existing information systems, or if our technology products do not operate as intended, our business could be materially and adversely affected.
  • If we sustain cyber-attacks or other privacy or data security incidents resulting in security breaches disrupting our operations or resulting in the unintended dissemination of protected personal information or proprietary or confidential
  • information, we could suffer a loss of revenue and increased costs, exposure to significant liability, reputational harm and other serious negative consequences.
  • If we fail to develop and maintain satisfactory relationships with health care payers, physicians, hospitals and other service providers, our business could be materially and adversely affected.
  • We are routinely subject to various legal actions, which could damage our reputation and, if resolved unfavorably, could result in substantial penalties or monetary damages and materially and adversely affect our results of operations, financial position and cash flows.
  • Any failure by us to manage successfully our strategic alliances or complete, manage or integrate acquisitions and other significant strategic transactions or relationships domestically or outside the United States could materially and adversely affect our business, prospects, results of operations, financial position and cash flows.
  • Our sales performance will suffer if we do not adequately attract, retain and provide support to a network of independent producers and consultants.
  • Unfavorable economic conditions could materially and adversely affect our revenues and our results of operations.
  • Our failure to attract, develop, retain, and manage the succession of key employees and executives could adversely affect our business, results of operations and future performance.
  • Our investment portfolio may suffer losses which could adversely affect our results of operations, financial position and cash flows.
  • If the value of our intangible assets is materially impaired, our results of operations, equity and credit ratings could be materially and adversely affected.
  • If we are not able to protect our proprietary rights to our databases, software and related products, our ability to market our knowledge and information-related businesses could be hindered and our results of operations, financial position and cash flows could be materially and adversely affected.
  • Any downgrades in our credit ratings could adversely affect our business, financial condition and results of operations.
  • Risks Related to the Regulation of Our Business
  • Our business activities are highly regulated and new laws or regulations or changes in existing laws or regulations or their enforcement or application could materially and adversely affect our business.
  • As a result of our participation in various government health care programs, both as a payer and as a service provider to payers, we are exposed to additional risks associated with program funding, enrollments, payment adjustments, audits and government investigations which could materially and adversely affect our business, results of operations, financial position and cash flows.
  • Our businesses providing pharmacy care services face regulatory and operational risks and uncertainties which may differ from the risks of our other businesses.
  • If we fail to comply with applicable privacy, security and data laws, regulations and standards, including with respect to third-party service providers utilizing protected personal information on our behalf, our business, reputation, results of operations, financial position and cash flows could be materially and adversely affected.
  • Restrictions on our ability to obtain funds from our regulated subsidiaries could materially and adversely affect our results of operations, financial position and cash flows.
Management Discussion
  • ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
  • Readers are cautioned that the statements, estimates, projections or outlook contained in this Management's Discussion and Analysis of Financial Condition and Results of Operations, including discussions regarding financial prospects, economic conditions, trends and uncertainties contained in this Item 2, may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA). These forward-looking statements involve risks and uncertainties that may cause our actual results to differ materially from the results discussed or implied in the forward-looking statements. A description of some of the risks and uncertainties is set forth in Part I, Item 1A, “Risk Factors” in our 2021 10-K and in the discussion below.
  • UnitedHealth Group Incorporated is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone. Our two distinct, yet complementary business platforms — Optum and UnitedHealthcare — are working to help build a modern, high-performing health system through improved access, affordability, outcomes and experiences for the individuals and organizations we are privileged to serve.

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: assigned, Bureau, CFPB, coinciding, consideration, deductible, forma, lagged, occurred, preliminary, pro, rapidly, relationship, valuation
Removed: efficiency, high

Patents

Utility
Intra-oral Device for Facilitating Communication
22 Sep 22
A method comprising determining, by a processing system, based on a first oral gesture detected by an intra-oral device located in a mouth of a user, an intended communication partner from among a plurality of available communication partners; determining, by the processing system, a message based on a series of one or more second oral gestures detected by the intra-oral device; and sending, by the processing system, the message to a communication device associated with the intended communication partner.
Utility
Relational Database Retrieval Procedures for Cohort-wise Data Comparisons
22 Sep 22
Embodiments of the present disclosure provide methods, apparatus, systems, computing devices, and computing entities for generating a comparison data value for each attribute of interest for one or more attributes of interest associated with a dataset.
Utility
Prioritized data object processing under processing time constraints
20 Sep 22
Systems and methods are configured to perform prioritized processing of a plurality of processing objects under a time constraint.
Utility
Apparatus and method for improved interface-based decision analysis
20 Sep 22
An apparatus, method, and computer program product for the improved development of training data sets for use in connection with machine learning models capable of operating on natural language data records and other unstructured data in a network environment.
Utility
Optimizing Lab Specimen from Collection to Utilization
15 Sep 22
A system includes sample containers and a computing system.